secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2026-06-02T20:15:54+00:00
Accession:  0001040130-26-000016
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Q4 sales fall 15.6% to $42.8M; FY net loss widens to $57.3M on goodwill impairment
--------------------------------------------------------------------------------

- Q4 net sales $42.8M (down 15.6% YoY); FY net sales $179M (down 21.1%) on lower prescription sales.
- Q4 net loss narrowed to $4.1M ($0.19/sh) from $11.6M; FY net loss widened to $57.3M ($2.74/sh) from $6.3M.
- FY adjusted EBITDA -$15.4M (vs +$0.7M) due to $26.7M goodwill impairment and $4.5M severance/investigation.
- Board evaluated unsolicited buyout proposals at $4.00-$4.25/sh but opted not to pursue; open to future offers.
- Management cites sequential QoQ sales uptick, cost reductions, and B2B expansion (Rural King fulfillment deal).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/0001040130-26-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/pets-20260602.htm
  HTML page:      https://secwatch.observer/filing/0001040130-26-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer